Author(s): Skinner J, Skinner A
Abstract Share this page
Abstract Levomepromazine (previously known as methotrimeprazine), despite virtually no high quality scientific data to support its use, has become a very popular antiemetic for use in patients with advanced cancer. This article considers the reasons for this.
This article was published in Hosp Med
and referenced in Journal of Environmental Analytical Chemistry